Neteera Technologies Ltd., a Jerusalem, Israel-based patient monitoring startup, closed a ~$13M Series B funding round.
The round was led by Aescuvest, with participation from Omega Healthcare Investors (NYSE: OHI), Nanz Family Office, Ankor Holding and Esas Private Equity. In addition, Neteera and Omega entered into a strategic partnership to offer Neteera’s technology to Omega’s healthcare operating partners.
The company intends to use the funds to accelerate sales, production and deployment of its contactless patient monitoring solution and further feature development for its proprietary medical sensing platform.
Led by CEO Isaac Litman, Neteera provides an FDA-cleared continuous, contactless, passive vital signs and bio-data monitoring solution that gives access to patient monitoring both for the crisis ridden healthcare system and home health. The sensing platform eliminates the need for device manipulation, removal of clothing, and caregiver presence. The technology is a based on a safe, maintenance-free, sub-THZ micro-radar on chip sensor solution that protects privacy as it is not based on a camera.
FinSMEs
25/04/2023